Evaxion Ebt Per Ebit from 2010 to 2024

EVAX Stock  USD 1.14  0.05  4.20%   
Evaxion Biotech Ebt Per Ebit yearly trend continues to be fairly stable with very little volatility. Ebt Per Ebit is likely to outpace its year average in 2024. During the period from 2010 to 2024, Evaxion Biotech Ebt Per Ebit regression line of annual values had r-squared of  0.31 and arithmetic mean of  1.08. View All Fundamentals
 
Ebt Per Ebit  
First Reported
2010-12-31
Previous Quarter
1.03234671
Current Value
1.13
Quarterly Volatility
0.06276456
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Evaxion Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Evaxion Biotech's main balance sheet or income statement drivers, such as Interest Income of 1.4 M, Depreciation And Amortization of 330.1 K or Interest Expense of 1 M, as well as many indicators such as Price To Sales Ratio of 206, Dividend Yield of 0.0 or Days Sales Outstanding of 4.3 K. Evaxion financial statements analysis is a perfect complement when working with Evaxion Biotech Valuation or Volatility modules.
  
Check out the analysis of Evaxion Biotech Correlation against competitors.

Latest Evaxion Biotech's Ebt Per Ebit Growth Pattern

Below is the plot of the Ebt Per Ebit of Evaxion Biotech AS over the last few years. It is Evaxion Biotech's Ebt Per Ebit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Evaxion Biotech's overall financial position and show how it may be relating to other accounts over time.
Ebt Per Ebit10 Years Trend
Slightly volatile
   Ebt Per Ebit   
       Timeline  

Evaxion Ebt Per Ebit Regression Statistics

Arithmetic Mean1.08
Geometric Mean1.08
Coefficient Of Variation5.81
Mean Deviation0.05
Median1.11
Standard Deviation0.06
Sample Variance0
Range0.1824
R-Value(0.56)
Mean Square Error0
R-Squared0.31
Significance0.03
Slope(0.01)
Total Sum of Squares0.06

Evaxion Ebt Per Ebit History

2024 1.13
2023 1.03
2022 0.95
2021 0.96
2020 1.0

About Evaxion Biotech Financial Statements

Evaxion Biotech investors use historical fundamental indicators, such as Evaxion Biotech's Ebt Per Ebit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Evaxion Biotech. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Ebt Per Ebit 1.03  1.13 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Evaxion Stock Analysis

When running Evaxion Biotech's price analysis, check to measure Evaxion Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evaxion Biotech is operating at the current time. Most of Evaxion Biotech's value examination focuses on studying past and present price action to predict the probability of Evaxion Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evaxion Biotech's price. Additionally, you may evaluate how the addition of Evaxion Biotech to your portfolios can decrease your overall portfolio volatility.